ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 519 | -16.2% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 619 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | – | 619 | +519.0% | 0.00% | – |
Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 100 | -84.1% | 0.00% | – |
Q3 2017 | $3,000 | -93.0% | 630 | -93.2% | 0.00% | -100.0% |
Q2 2017 | $43,000 | +1333.3% | 9,290 | +1374.6% | 0.00% | – |
Q1 2017 | $3,000 | 0.0% | 630 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | -25.0% | 630 | +18.9% | 0.00% | – |
Q3 2016 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 530 | +60.6% | 0.00% | – |
Q4 2015 | $4,000 | – | 330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |